Search
for
Sort by
Research 151–180 of 1000+
- Features of the immune status and comorbidities in children with alopecia areata
- 177 Chronic graft-versus-host disease exhibits distinct Th1-skewing and barrier abnormalities in the skin
- 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid
- 1617 Impact of type 2 cytokines on the keratinocytes-s. aureus interaction
- Lichen planus – A refractory autoimmune disorder
- T helper type 2 immune response in alopecia areata
- Complete hair regrowth in a young male with severe atopic dermatitis and alopecia areata after dupilumab: probably more than a coincidence
- Referee report. For: Molecular mediators involved in skin healing: a narrative review [version 1; peer review: 1 approved with reservations]
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
- 035 Expansion of bacterial phosphatidylglycerol reactive CD4+ T cells in atopic dermatitis
- Dupilumab: Friend or Foe to Alopecia Areata?
- 708 SIG-1451: A topical anti-inflammatory new chemical entity for atopic dermatitis (AD)
- Influence of Gushen Shengfa Pills Combined Wuling Capsules on Th1/Th2 Cytokines in Patients with Alopecia Areata Disease
- Increased expression of nerve growth factor and neurokinin-1 alarm the hair loss in female with trichodynia
- The Anti-atopic Lotions Containing Fucoidan Extracted from Ecklonia Cava Impact on Hairless Mice Atopic Dermatitis Skin
- 益氣補血湯이 C57BL/6 마우스의 育毛촉진 및 Cytokine 변화에 미치는 영향
- Cytokine profiling of alopecia areata phenotypic subsets
- Topische Immuntherapie mit Diphenylcyclopropenon bei verschiedenen Typen der Alpecia areata: Assoziation zu klinischen Parametern und einem funktionellen Genpolymorphismus des Interleukin-6-Promotors
- Dupilumab and alopecia: A Janus effect
- LB1007 Systemic treatment with a KLK5 inhibitor shows efficacy in a murine model of Netherton syndrome
- Alopecia Areata: Current Treatments and New Directions
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- CUTANEOUS T-CELL LYMPHOMA
- Assessment of Interleukin-17A and Interleukin-2 Serum Levels in Patients with Alopecia Areata
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- Therapeutic Effects of Alkaloids on Influenza: A Systematic Review and Meta-Analysis of Preclinical Studies
- EFFECT OF PLASMATHERAPY ON THE IMMUNE STATUS OF PATIENTS WITH VITILIGO
- 709 Nitric oxide-releasing topical therapeutic agent for atopic dermatitis
- Association Between Interleukin 18 Polymorphisms and Alopecia Areata in Koreans